American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Mondelez International
MDLZ
|
+$225M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$165M |
| 3 |
Visa
V
|
+$152M |
| 4 |
Booz Allen Hamilton
BAH
|
+$151M |
| 5 |
BorgWarner
BWA
|
+$149M |
Top Sells
| 1 |
PepsiCo
PEP
|
+$273M |
| 2 |
LPNT
LifePoint Health, Inc.
LPNT
|
+$268M |
| 3 |
Meta Platforms (Facebook)
META
|
+$248M |
| 4 |
Gilead Sciences
GILD
|
+$222M |
| 5 |
Johnson & Johnson
JNJ
|
+$214M |
Sector Composition
| 1 | Financials | 16.58% |
| 2 | Technology | 14.76% |
| 3 | Healthcare | 13.64% |
| 4 | Consumer Discretionary | 12.38% |
| 5 | Industrials | 10.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Teekay
TK
$722M
| $2.36M | ﹤0.01% |
349,484
+4,157
| +1% | +$28K |
|
1002
Fidelity National Information Services
FIS
$34.9B
| $2.35M | ﹤0.01% |
+21,587
| New | +$2.35M |
|
1003
Esperion Therapeutics
ESPR
$573M
| $2.33M | ﹤0.01% |
52,544
+23,769
| +83% | +$1.05M |
|
1004
Primoris Services
PRIM
$6.59B
| $2.32M | ﹤0.01% |
93,576
-175,806
| -65% | -$4.36M |
|
1005
Columbus McKinnon
CMCO
$415M
| $2.29M | ﹤0.01% |
57,922
-4,113
| -7% | -$163K |
|
1006
McGrath RentCorp
MGRC
$3.01B
| $2.28M | ﹤0.01% |
41,908
-51,886
| -55% | -$2.83M |
|
1007
Sandstorm Gold
SAND
$3.46B
| $2.25M | ﹤0.01% |
604,700
| – | – |
|
|
GBT
1008
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $2.24M | ﹤0.01% |
58,882
-419
| -0.7% | -$15.9K |
|
|
HIFR
1009
DELISTED
InfraREIT, Inc.
HIFR
| $2.22M | ﹤0.01% |
105,105
+19,871
| +23% | +$420K |
|
1010
Covenant Logistics
CVLG
$576M
| $2.21M | ﹤0.01% |
152,240
+1,844
| +1% | +$26.8K |
|
|
ANAT
1011
DELISTED
American National Group, Inc. Common Stock
ANAT
| $2.17M | ﹤0.01% |
+16,780
| New | +$2.17M |
|
|
OMN
1012
DELISTED
OMNOVA Solutions Inc.
OMN
| $2.15M | ﹤0.01% |
218,195
+3,275
| +2% | +$32.3K |
|
1013
Motorola Solutions
MSI
$80.3B
| $2.14M | ﹤0.01% |
16,464
+378
| +2% | +$49.2K |
|
|
CCXI
1014
DELISTED
ChemoCentryx, Inc.
CCXI
| $2.14M | ﹤0.01% |
169,037
+5,166
| +3% | +$65.3K |
|
1015
Watsco
WSO
$15.5B
| $2.11M | ﹤0.01% |
11,857
-1,697
| -13% | -$302K |
|
|
XOXO
1016
DELISTED
Xo Group Inc
XOXO
| $2.11M | ﹤0.01% |
+61,150
| New | +$2.11M |
|
1017
Cactus
WHD
$2.74B
| $2.1M | ﹤0.01% |
54,952
+15,283
| +39% | +$585K |
|
1018
Universal Insurance Holdings
UVE
$719M
| $2.09M | ﹤0.01% |
43,139
+674
| +2% | +$32.7K |
|
1019
ANI Pharmaceuticals
ANIP
$2.12B
| $2.08M | ﹤0.01% |
36,845
+417
| +1% | +$23.6K |
|
1020
Natural Health Trends
NHTC
$53.9M
| $2.03M | ﹤0.01% |
87,160
-6,506
| -7% | -$151K |
|
1021
Comcast
CMCSA
$122B
| $2.02M | ﹤0.01% |
57,072
-388,445
| -87% | -$13.8M |
|
1022
iShares MSCI Japan ETF
EWJ
$15.7B
| $1.96M | ﹤0.01% |
32,486
| – | – |
|
|
CLVS
1023
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.95M | ﹤0.01% |
66,266
-244
| -0.4% | -$7.17K |
|
1024
Adient
ADNT
$1.95B
| $1.92M | ﹤0.01% |
48,739
+2,152
| +5% | +$84.6K |
|
1025
Brixmor Property Group
BRX
$8.57B
| $1.91M | ﹤0.01% |
+108,808
| New | +$1.91M |
|